Alemtuzumab treatment exemplifies discordant immune effects of blood and cerebrospinal fluid in multiple sclerosis
收藏NIAID Data Ecosystem2026-05-01 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/SRP428751
下载链接
链接失效反馈官方服务：
资源简介：
We here analyzed CSF and blood from two relapsing-remitting multiple sclerosis (RRMS) patients early after peripheral leukocyte depletion with the anti-CD52 antibody alemtuzumab compared to untreated RRMS and control patients using single cell RNA-sequencing. Overall design: Single-cell RNA sequencing data of paired cerebrospinal fluid and blood of two RRMS patients after alemtuzumab treatment.
创建时间：
2023-07-15
